There aren’t many tomorrows left; it’s time to forfeit a bit of quality for quantity’s sake

Should non-contenders be barred from trading with contenders down the stretch?

Checking in on an attempt to nurse an April infirmary into a September juggernaut.

Reading the market and taking advantage of last-minute keeper deals

What must we establish to rightly claim credit for our predictions?

Giving Carl Pavano’s performance the respect it deserves.

More than halfway though the season, are underperforming players still buy-low candidates, or are they sunken costs?

It can be quite difficult to evaluate the benefits of trades involving many players.

To double down or buy insurance?

What are we costing ourselves by holding on to our fringe assets?